Bill Text: NY A03830 | 2019-2020 | General Assembly | Amended


Bill Title: Relates to the definition of the practice of pharmacy.

Spectrum: Bipartisan Bill

Status: (Introduced - Dead) 2020-12-04 - print number 3830a [A03830 Detail]

Download: New_York-2019-A03830-Amended.html



                STATE OF NEW YORK
        ________________________________________________________________________

                                         3830--A

                               2019-2020 Regular Sessions

                   IN ASSEMBLY

                                    January 31, 2019
                                       ___________

        Introduced  by M. of A. McDONALD, BLANKENBUSH, TAGUE, ARROYO, WALCZYK --
          Multi-Sponsored by -- M. of A. SAYEGH -- read once and referred to the
          Committee on Higher Education -- recommitted to the Committee on High-
          er Education in accordance with Assembly Rule 3, sec. 2  --  committee
          discharged, bill amended, ordered reprinted as amended and recommitted
          to said committee

        AN  ACT to amend the education law, in relation to the definition of the
          practice of pharmacy

          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:

     1    Section  1.  Subdivision  22  of section 6802 of the education law, as
     2  amended by section 2 of part DD of chapter 57 of the laws  of  2018,  is
     3  amended to read as follows:
     4    22.  "Administer",  for the purpose of section sixty-eight hundred one
     5  of this article, means:
     6    a. (1) the direct application of an immunizing agent to adults, wheth-
     7  er by injection, ingestion, inhalation or any other means, pursuant to a
     8  patient specific order or non-patient  specific  regimen  prescribed  or
     9  ordered  by a physician or certified nurse practitioner, who has a prac-
    10  tice site in the county or adjoining county in which the immunization is
    11  administered, for  immunizations  to  prevent  influenza,  pneumococcal,
    12  acute  herpes  zoster,  meningococcal, tetanus, diphtheria, COVID-19, or
    13  pertussis disease and medications required for  emergency  treatment  of
    14  anaphylaxis.  If  the commissioner of health determines that there is an
    15  outbreak of disease, or that there is the imminent threat of an outbreak
    16  of disease, then the commissioner of  health  may  issue  a  non-patient
    17  specific regimen applicable statewide.
    18    [b.]  (2)  the  direct  application of an immunizing agent to children
    19  between the ages of two and eighteen years of age, whether by injection,
    20  ingestion, inhalation or any other means, pursuant to a patient specific
    21  order or non-patient specific regimen prescribed or ordered by a  physi-
    22  cian  or  certified  nurse  practitioner, who has a practice site in the
    23  county or adjoining county in which the  immunization  is  administered,
    24  for immunization to prevent influenza and medications required for emer-

         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD00670-08-0

        A. 3830--A                          2

     1  gency  treatment of anaphylaxis resulting from such immunization. If the
     2  commissioner of health determines that there is an outbreak of  influen-
     3  za,  or  that  there is the imminent threat of an outbreak of influenza,
     4  then the commissioner of health may issue a non-patient specific regimen
     5  applicable statewide.
     6    b. The injection of medications for the treatment of mental health and
     7  substance  use disorder, as prescribed or ordered by a licensed prescri-
     8  ber in this state and in accordance with regulations promulgated by  the
     9  commissioner and the department of health in consultation with the board
    10  of pharmacy, and any other state agencies as necessary, providing that:
    11    (1)  Such administration is conducted pursuant to a valid prescription
    12  or order that authorizes a pharmacist to administer medications for  the
    13  treatment of mental health and substance use disorder and the pharmacist
    14  notifies the licensed prescriber that the administration is complete.
    15    (2)  Such  prescription  may be subject to reassessment at appropriate
    16  intervals, as determined by the licensed prescriber.
    17    (3) Such activity is conducted in accordance with regulations  promul-
    18  gated  or  adopted  by the commissioner and the department of health, in
    19  consultation with the board of pharmacy, and any other  state  agencies,
    20  as necessary, which shall include requirements for the following:
    21    (i)  Training  accredited  by  the  accreditation council for pharmacy
    22  education, that may include  educational  experiences  obtained  through
    23  pharmacy school curricula, or a similar health authority or professional
    24  body  appropriate  for  the  medications  being  administered  and their
    25  respective patient populations. Such training must  be  satisfactory  to
    26  the  commissioner and the department of health, in consultation with the
    27  board of pharmacy and any other  state  agencies,  as  necessary,  which
    28  shall  include, but not be limited to learning modules on techniques for
    29  administration by injections, indications, precautions, and  contraindi-
    30  cations  in  the use of agent or agents; record keeping and information;
    31  and  handling  emergencies,  including  anaphylaxis,  needle-sticks  and
    32  cardiopulmonary resuscitation.
    33    (ii) Maintaining continued competency regarding the populations served
    34  and medications administered.
    35    (iii)  Pre-administration  patient  consent  and  education  regarding
    36  common side effects, drug interactions,  injection  site  reactions  and
    37  other information routinely provided to patients upon dispensing.
    38    (iv)  When  administering  an  injection in a pharmacy, the pharmacist
    39  shall provide an area for the injection that provides for the  patient's
    40  privacy.
    41    (v)  Record keeping and reporting of such administration by electronic
    42  transmission or facsimile to the patient's licensed prescriber, and,  to
    43  the extent practicable, make himself or herself available to discuss the
    44  outcome  of  such  injection,  including any adverse reactions, with the
    45  licensed prescriber.
    46    § 2. Subdivision 22 of section 6802 of the education law,  as  amended
    47  by chapter 110 of the laws of 2020, is amended to read as follows:
    48    22.  "Administer",  for the purpose of section sixty-eight hundred one
    49  of this article, means:
    50    a. (1) the direct application of an immunizing agent to adults, wheth-
    51  er by injection, ingestion, inhalation or any other means, pursuant to a
    52  patient specific order or non-patient  specific  regimen  prescribed  or
    53  ordered  by a physician or certified nurse practitioner, who has a prac-
    54  tice site in the county or adjoining county in which the immunization is
    55  administered, for  immunizations  to  prevent  influenza,  pneumococcal,
    56  acute  herpes  zoster,  meningococcal, tetanus, diphtheria, COVID-19, or

        A. 3830--A                          3

     1  pertussis disease and medications required for  emergency  treatment  of
     2  anaphylaxis.  If  the commissioner of health determines that there is an
     3  outbreak of disease, or that there is the imminent threat of an outbreak
     4  of  disease,  then  the  commissioner  of health may issue a non-patient
     5  specific regimen applicable statewide.
     6    [b.] (2) the direct application of an  immunizing  agent  to  children
     7  between the ages of two and eighteen years of age, whether by injection,
     8  ingestion, inhalation or any other means, pursuant to a patient specific
     9  order  or non-patient specific regimen prescribed or ordered by a physi-
    10  cian or certified nurse practitioner, who has a  practice  site  in  the
    11  county  or  adjoining  county in which the immunization is administered,
    12  for immunization to prevent influenza and medications required for emer-
    13  gency treatment of anaphylaxis resulting from such immunization. If  the
    14  commissioner  of health determines that there is an outbreak of influen-
    15  za, or that there is the imminent threat of an  outbreak  of  influenza,
    16  then the commissioner of health may issue a non-patient specific regimen
    17  applicable statewide.
    18    b. The injection of medications for the treatment of mental health and
    19  substance  use disorder, as prescribed or ordered by a licensed prescri-
    20  ber in this state and in accordance with regulations promulgated by  the
    21  commissioner  and  the  department  of  health, in consultation with the
    22  board of pharmacy, and any other state agencies, as necessary, providing
    23  that:
    24    (1) Such administration is conducted pursuant to a valid  prescription
    25  or  order that authorizes a pharmacist to administer medications for the
    26  treatment of mental health and substance use disorder and the pharmacist
    27  notifies the licensed prescriber that the administration is complete.
    28    (2) Such prescription may be subject to  reassessment  at  appropriate
    29  intervals, as determined by the licensed prescriber.
    30    (3)  Such activity is conducted in accordance with regulations promul-
    31  gated or adopted by the commissioner and the department  of  health,  in
    32  consultation  with  the board of pharmacy, and any other state agencies,
    33  as necessary, which shall include requirements for the following:
    34    (i) Training accredited by  the  accreditation  council  for  pharmacy
    35  education,  that  may  include  educational experiences obtained through
    36  pharmacy school curricula, or a similar health authority or professional
    37  body appropriate  for  the  medications  being  administered  and  their
    38  respective  patient  populations.  Such training must be satisfactory to
    39  the commissioner and the department of health, in consultation with  the
    40  board  of  pharmacy  and  any  other state agencies, as necessary, which
    41  shall include, but not be limited to learning modules on techniques  for
    42  administration  by injections, indications, precautions, and contraindi-
    43  cations in the use of agent or agents; record keeping  and  information;
    44  and  handling  emergencies,  including  anaphylaxis,  needle-sticks  and
    45  cardiopulmonary resuscitation.
    46    (ii) Maintaining continued competency regarding the populations served
    47  and medications administered.
    48    (iii)  Pre-administration  patient  consent  and  education  regarding
    49  common  side  effects,  drug  interactions, injection site reactions and
    50  other information routinely provided to patients upon dispensing.
    51    (iv) When administering an injection in  a  pharmacy,  the  pharmacist
    52  shall  provide an area for the injection that provides for the patient's
    53  privacy.
    54    (v) Record keeping and reporting of such administration by  electronic
    55  transmission  or facsimile to the patient's licensed prescriber, and, to
    56  the extent practicable, make himself or herself available to discuss the

        A. 3830--A                          4

     1  outcome of such injection, including any  adverse  reactions,  with  the
     2  licensed prescriber.
     3    §  3.  Subdivision 22 of section 6802 of the education law, as amended
     4  by section 2 of part DD of chapter 57 of the laws of 2018, is amended to
     5  read as follows:
     6    22. "Administer", for the purpose of section sixty-eight  hundred  one
     7  of this article, means:
     8    a. (1) the direct application of an immunizing agent to adults, wheth-
     9  er by injection, ingestion, inhalation or any other means, pursuant to a
    10  patient  specific  order  or  non-patient specific regimen prescribed or
    11  ordered by a physician or certified nurse practitioner, who has a  prac-
    12  tice site in the county or adjoining county in which the immunization is
    13  administered,  for  immunizations  to  prevent  influenza, pneumococcal,
    14  acute herpes zoster, meningococcal, tetanus,  diphtheria,  COVID-19,  or
    15  pertussis  disease  and  medications required for emergency treatment of
    16  anaphylaxis. If the commissioner of health determines that there  is  an
    17  outbreak of disease, or that there is the imminent threat of an outbreak
    18  of  disease,  then  the  commissioner  of health may issue a non-patient
    19  specific regimen applicable statewide.
    20    [b.] (2) the direct application of an  immunizing  agent  to  children
    21  between the ages of two and eighteen years of age, whether by injection,
    22  ingestion, inhalation or any other means, pursuant to a patient specific
    23  order  or non-patient specific regimen prescribed or ordered by a physi-
    24  cian or certified nurse practitioner, who has a  practice  site  in  the
    25  county  or  adjoining  county in which the immunization is administered,
    26  for immunization to prevent influenza and medications required for emer-
    27  gency treatment of anaphylaxis resulting from such immunization. If  the
    28  commissioner  of health determines that there is an outbreak of influen-
    29  za, or that there is the imminent threat of an  outbreak  of  influenza,
    30  then the commissioner of health may issue a non-patient specific regimen
    31  applicable statewide.
    32    b. The injection of medications for the treatment of mental health and
    33  substance use disorders, as prescribed or ordered by a licensed prescri-
    34  ber  in this state and in accordance with regulations promulgated by the
    35  commissioner and the department of  health,  in  consultation  with  the
    36  board of pharmacy, and any other state agencies, as necessary, providing
    37  that:
    38    (1)  Such administration is conducted pursuant to a valid prescription
    39  or order that authorizes a pharmacist to administer medications for  the
    40  treatment of mental health and substance use disorder and the pharmacist
    41  notifies the licensed prescriber that the administration is complete.
    42    (2)  Such  prescription  may be subject to reassessment at appropriate
    43  intervals, as determined by the licensed prescriber.
    44    (3) Such activity is conducted in accordance with regulations  promul-
    45  gated  or  adopted  by the commissioner and the department of health, in
    46  consultation with the board of pharmacy, and any other  state  agencies,
    47  as necessary, which shall include requirements for the following:
    48    (i)  Training  accredited  by  the  accreditation council for pharmacy
    49  education, that may include  educational  experiences  obtained  through
    50  pharmacy school curricula, or a similar health authority or professional
    51  body  appropriate  for  the  medications  being  administered  and their
    52  respective patient populations. Such training must  be  satisfactory  to
    53  the  commissioner and the department of health, in consultation with the
    54  board of pharmacy and any other  state  agencies,  as  necessary,  which
    55  shall  include, but not be limited to learning modules on techniques for
    56  administration by injections, indications, precautions, and  contraindi-

        A. 3830--A                          5

     1  cations  in  the use of agent or agents; record keeping and information;
     2  and  handling  emergencies,  including  anaphylaxis,  needle-sticks  and
     3  cardiopulmonary resuscitation.
     4    (ii) Maintaining continued competency regarding the populations served
     5  and medications administered.
     6    (iii)  Pre-administration  patient  consent  and  education  regarding
     7  common side effects, drug interactions,  injection  site  reactions  and
     8  other information routinely provided to patients upon dispensing.
     9    (iv)  When  administering  an  injection in a pharmacy, the pharmacist
    10  shall provide an area for the injection that provides for the  patient's
    11  privacy.
    12    (v)  Record keeping and reporting of such administration by electronic
    13  transmission or facsimile to the patient's licensed prescriber, and,  to
    14  the extent practicable, make himself or herself available to discuss the
    15  outcome  of  such  injection,  including any adverse reactions, with the
    16  licensed prescriber.
    17    § 4. Section 6801 of the education law is  amended  by  adding  a  new
    18  subdivision 6 to read as follows:
    19    6. A licensed pharmacist may administer injectable medications for the
    20  treatment  of mental health and substance use disorder, as prescribed or
    21  ordered by a licensed prescriber in this state and  in  accordance  with
    22  regulations  promulgated  by  the  commissioner in consultation with the
    23  board of pharmacy, and any other state agencies, as necessary.
    24    § 5. This act shall take effect on the one hundred eightieth day after
    25  it shall have become a law; provided, however, that:
    26    a. the amendments to subdivision 22 of section 6802 of  the  education
    27  law  made  by section one of this act shall be subject to the expiration
    28  and reversion of such subdivision pursuant to section 4 of  chapter  110
    29  of  the  laws of 2020, as amended, when upon such date the provisions of
    30  section two of this act shall take effect;  provided,  however,  if  the
    31  provisions  of section two of this act shall not have taken effect prior
    32  to the repeal of such subdivision pursuant to section 8 of  chapter  563
    33  of  the  laws  of 2008, as amended, such amendments shall not affect the
    34  repeal of such subdivision and shall be deemed to repeal therewith;
    35    b. provided, further, the amendments to subdivision 22 of section 6802
    36  of the education law made by section two of this act shall  take  effect
    37  on  the  same date and in the same manner as section 2 of chapter 110 of
    38  the laws of 2020, takes effect; provided, however, if section 2 of chap-
    39  ter 110 of the laws of 2020 takes effect prior to the effective date  of
    40  this  act,  section  two of this section shall not take effect until the
    41  one hundred eightieth day after it shall have  become  a  law;  provided
    42  that such amendments made by section two of this act shall be subject to
    43  the  expiration  and reversion of such subdivision pursuant to section 4
    44  of chapter 110 of the laws of 2020, as amended, when upon such date  the
    45  provisions of section three of this act shall take effect;
    46    c.  provided, further that the amendments to subdivision 22 of section
    47  6802 of the education law made by section three of this  act  shall  not
    48  affect  the  repeal  of  such  subdivision and shall be deemed to repeal
    49  therewith; and
    50    d. provided, further, the amendments to section 6801 of the  education
    51  law  made by section four of this act shall not affect the expiration of
    52  such section and shall be deemed  repealed  therewith.  Effective  imme-
    53  diately, the addition, amendment and/or repeal of any rule or regulation
    54  necessary  for  the implementation of this act on its effective date are
    55  authorized  to be made and completed by the commissioner of education on
    56  or before such date.
feedback